Acadia Pharmaceuticals Inc (ACAD) stock
ACADNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 17/3041% below fair value
$18.75+0.61 (+3.36%)
Close on Nov 13, 2026Market cap $3.23BP/E 8.9Yield –
Acadia Pharmaceuticals statistics
97 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.
Important dates
- Next earnings
- Feb 24, 2027 (estimated, during market hours)
- Last ex-dividend date
- No dividends
- Fundamentals through
- Sep 30, 2026
- Share price as of
- Nov 13, 2026
Valuation ratiosIndustry
- P/TBV Ratio
- 2.58
- 2.22
- P/OCF Ratio
- 33.12
- 12.99
Enterprise valuationIndustry
- EV / Sales
- 1.87
- 2.57
- EV / EBIT
- 18.43
- 19.31
- EV / FCF
- 27.50
- 22.27
Share statisticsIndustry
- Shares Change (YoY)
- 2.85%
- 10.8%
- Shares Change (QoQ)
- 0.38%
- 0.50%
- Float
- 124M
- 49M
- Shares Held by Insiders
- 27.8%
- 11.7%
- Shares Held by Institutions
- 97.9%
- 56.4%
Short sellingIndustry
- Short Interest
- 8M
- –
- Short Interest Change
- -8.54%
- -0.80%
- Short % of Float
- 6.68%
- 9.01%
- Short % of Shares Outstanding
- 4.83%
- 6.30%
- Days to Cover
- 5.94
- 5.15
Stock price statisticsIndustry
- 52-Week High
- $30.96
- –
- 52-Week Low
- $15.86
- –
- 20-Day Moving Average
- $19.85
- –
- 50-Day Moving Average
- $21.79
- –
- 200-Day Moving Average
- $23.33
- –
- Average True Range (14)
- $1.06
- –
- Price Change (1 Week)
- -11.7%
- -1.15%
- Price Change (1 Month)
- -4.87%
- -4.87%
- Price Change (3 Months)
- -35.4%
- -21.0%
- Price Change (6 Months)
- -12.4%
- -20.6%
- Price Change (YTD)
- -29.8%
- -23.6%
- Price Change (1 Year)
- -22.3%
- -22.4%
- Price Change (3 Years)
- -19.2%
- -29.5%
- Price Change (5 Years)
- -9.20%
- -77.9%
- Price Change (10 Years)
- -35.5%
- -65.4%
- Average Volume (10 Days)
- 4M
- –
- Average Volume (20 Days)
- 3M
- –
- Average Volume (90 Days)
- 2M
- –
- Relative Volume
- 0.88
- 0.70
- Relative Strength Index (14)
- 42.0
- 43.4
- Volatility (1 Year)
- 45.3%
- 80.1%
- Beta (5 Years)
- 0.78
- 1.07
MarginsIndustry
- Pretax Margin
- 13.1%
- -11.6%
- EBITDA Margin
- 10.2%
- -27.7%
- FCF Margin
- 6.82%
- -9.56%
Returns on capitalIndustry
- Return on Equity (ROE)
- 31.4%
- -49.9%
- Return on Assets (ROA)
- 23.2%
- -40.6%
- Return on Invested Capital (ROIC)
- 50.8%
- -32.9%
- Return on Capital Employed (ROCE)
- 8.37%
- -37.9%
Financial positionIndustry
- Current Ratio
- 3.82
- 3.30
- Quick Ratio
- 3.42
- 2.39
GrowthIndustry
- Revenue Growth (YoY)
- 14.8%
- 6.82%
- Net Income Growth (YoY)
- 38.7%
- -14.4%
- EPS Growth (YoY)
- 35.5%
- -12.3%
- FCF Growth (YoY)
- -58.6%
- 6.85%
- Revenue Growth (3Y CAGR)
- 27.5%
- 2.25%
- Revenue Growth (5Y CAGR)
- 19.4%
- 6.41%
EfficiencyIndustry
- Asset Turnover
- 0.77
- 0.40
- Inventory Turnover
- 1.08
- 2.73
- Revenue Per Employee
- $1.51M
- $429.29K
- Profits Per Employee
- $453.92K
- -$689.41K
- Employee Count
- 798
- 74
- WACC
- 9.01%
- 10.2%
Income statement (TTM)Industry
- Pretax Income
- $157.21M
- -$12.95M
Balance sheetIndustry
- Net Cash (Debt)
- $976.45M
- $17.76M
- Net Cash Per Share
- $5.67
- $0.80
- Equity (Book Value)
- $1.39B
- $53.89M
- Book Value Per Share
- $8.05
- $1.50
- Tangible Book Value
- $1.25B
- $27.13M
- Working Capital
- $936.21M
- $79.99M
Cash flow (TTM)Industry
- Capital Expenditures
- -$15.55M
- -$1.00M
- FCF Per Share
- $0.48
- -$0.42
Dividends and yieldsIndustry
- Earnings Yield
- 11.2%
- -21.8%
- FCF Yield
- 2.54%
- -9.44%
- Buyback Yield
- -1.52%
- -0.76%
- Shareholder Yield
- -1.52%
- 0.00%
Taxes and interestIndustry
- Income Tax
- -$205.02M
- $73.00K
- Effective Tax Rate
- -130.4%
- 20.9%
Scores and fair valueIndustry
- Graham Number
- $19.51
- $19.34
- Graham Upside
- 4.03%
- -46.6%
- Altman Z-Score
- 4.94
- 0.23
- Piotroski F-Score
- 6
- 4
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.
| Period | ACAD | S&P 500 | Difference | ACAD per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | +0.7% | -3.0% | +3.7 pts | ||
| 3 months | -33.9% | -2.8% | −31.2 pts | ||
| Year to date | -29.8% | +11.5% | −41.3 pts | ||
| 1 year | -20.7% | +13.5% | −34.1 pts | ||
| 3 years | -16.4% | +77.7% | −94.1 pts | -5.8% | +21.1% |
| 5 years | -9.2% | +72.6% | −81.8 pts | -1.9% | +11.5% |
| 10 years | -34.9% | +308.2% | −343.1 pts | -4.2% | +15.1% |
Short interest
Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.
8M ACAD shares were sold short on Oct 30, 2026, down 8.5% from the previous report, or 6.68% of the shares available to trade. At recent volumes it would take 5.9 days to buy them back. Over the last 20 sessions, 29.9% of the volume reported to FINRA was short selling.
| Settlement date | Shares short | Change | Avg. daily volume | Days to cover |
|---|---|---|---|---|
| Oct 30, 2026 | 8,317,392 | -8.5% | 1,399,268 | 5.9 |
| Oct 15, 2026 | 9,094,151 | +9.9% | 1,986,923 | 4.6 |
| Sep 30, 2026 | 8,275,918 | -14.4% | 2,828,484 | 2.9 |
| Sep 15, 2026 | 9,666,972 | -0.7% | 1,338,393 | 7.2 |
| Aug 31, 2026 | 9,739,720 | +2.8% | 1,404,719 | 6.9 |
| Aug 14, 2026 | 9,478,912 | -12.3% | 2,090,088 | 4.5 |
| Jul 31, 2026 | 10,812,093 | -2.0% | 1,358,749 | 8.0 |
| Jul 15, 2026 | 11,029,444 | +0.7% | 1,448,908 | 7.6 |
| Jun 30, 2026 | 10,951,125 | -7.3% | 2,307,777 | 4.8 |
| Jun 15, 2026 | 11,812,790 | +0.5% | 1,047,620 | 11.3 |
| May 29, 2026 | 11,754,100 | +2.9% | 1,454,891 | 8.1 |
| May 15, 2026 | 11,424,605 | +2.4% | 1,946,766 | 5.9 |
Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.
See a number that looks wrong?